FAS and prostate carcinoma: The expression of Fas and PTEN have previously been found to be negatively correlated in prostate cancer [65], consistent with the negative correlation we identify between PTEN and FASLG in the PTEN wildtype breast cancer samples, suggestive of negative regulation at baseline.